Purchase Order 75D30122P14977
Award Date
8/30/22
Potential Completion Date
10/30/22
Potential Value
$10K
Federal Agency
CDC Pittsburgh
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Chamblee, GA 30341, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order contract to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $22,376.85 contract is for the provision of an ISEQ 100 SYSTEM, with a completion date of March 1, 2026. This award does not have a set-aside designation. Illumina has previously received prime federal contracts from agencies such as the NIH,...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $241,046.40 firm fixed-price purchase order to Illumina, Inc. to provide reagents and supplies. The award has no set-aside designation. Illumina is a manufacturer and provider of genetic sequencing instruments and analytical products. This award aligns with Illumina's past prime federal contracts to support genomic sequencing and analysis for various government agencies including the CDC,...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order contract to Illumina, Inc., a manufacturer of genetic sequencing and analysis instruments and reagents. The $20,634.75 contract is for the provision of ILLUMINA REAGENTS to support the agency's research and diagnostic activities. Illumina has a history of providing sequencing systems, consumables, and services to federal agencies like the NIH, USDA, and VA....
The Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents, for reagents to be used with Illumina's sequencing systems. The $219,192.00 contract does not have a set-aside designation and is intended to support the CDC's needs through August 31, 2022. Illumina has a history of providing sequencing equipment, consumables, and services to...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, for the provision of an ILLUMINA NS 1000 INSTRUMENT. The potential value of this award is $205,800.00. Illumina has previously received prime federal contract awards from various agencies like the NIH, CDC, USDA, and VA to provide a range of genomic sequencing systems, consumables, and...
This is a federal contract award to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $101,280.02, was awarded by the Centers for Disease Control and Prevention (CDC) for the provision of a reagent kit. The contract is a firm fixed price purchase order with no set-aside designation. Illumina has previously received prime federal contract awards from agencies such as the National Institutes of Health (NIH), U.S....
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents, for the procurement of a NEXTSEQ 1000 SEQUENCING SYSTEM. The total potential value of the award is $205,800.00 with a completion date of August 23, 2021. Illumina has a history of providing sequencing equipment, consumables, and services to federal agencies such as the National...
This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $85,056.40 contract is for the delivery of laboratory reagents, with an ultimate completion date of July 31, 2022. The contract does not have a set-aside designation. Illumina has previously received federal prime contract and subcontract awards from agencies like the National...
This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $247,057.60, is for the delivery of ISEQ REAGENTS with a period of performance through September 30, 2023. Illumina has previously been awarded prime federal contracts and subcontracts by agencies such as the National Institutes of Health, Department of...
This is a $80,453.34 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing products and services. The contract is for the provision of reagent products to support the CDC's genomic sequencing and analysis work. Illumina has a history of providing sequencing systems, reagents, and related services to federal agencies like the NIH, USDA, and VA for research and diagnostics. This award does not have...